Vaccine and Immunology

Emerging Infectious Diseases

Emerging infectious diseases (EIDs) pose ongoing threats to global health due to pathogen evolution, human-animal interactions, urbanization, and environmental changes. Viruses such as Ebola, Zika, and novel coronaviruses demonstrate the rapidity with which outbreaks can spread, underscoring the need for vigilant surveillance and timely vaccine development. Understanding pathogen biology, transmission dynamics, and host immune responses is critical for designing effective interventions. Integrating genomic sequencing, epidemiological modeling, and bioinformatics accelerates identification of novel targets for vaccines and therapeutics. Collaborative global networks monitor and share data to detect outbreaks early, enabling proactive responses. Vaccine development for EIDs requires flexible platforms capable of rapid adaptation to evolving pathogens, with considerations for safety, scalability, and equitable distribution. Addressing EIDs also demands investment in public health infrastructure, laboratory capacity, and community engagement to ensure preparedness and resilience against future epidemics.